Maximo F. Nougues, serving as Chief Financial Officer for Puma Biotechnology, Inc. (NASDAQ:PBYI), completed the sale of 9,386 shares in the company's common stock on July 6, 2026. The transaction resulted in a total value of $77,556, with each share sold at a price point of $8.263.
This divestiture was conducted under the parameters of a Rule 10b5-1(c) sell-to-cover program. The framework for this program was originally adopted on December 14, 2020. Following the execution of this sale, Mr. Nougues maintains a direct holding of 230,637 shares of Puma Biotechnology common stock.
The insider activity occurs against a backdrop of notable price movement for PBYI shares. The stock is currently trading in proximity to its 52-week high of $8.44. Over the preceding twelve-month period, the equity has delivered a return of 126%. Market analysis from InvestingPro indicates that the stock may be undervalued at present levels, with a Fair Value metric suggesting substantial upside potential. Investors seeking detailed valuation and growth analysis can access a comprehensive Pro Research Report, which covers PBYI and over 1,400 additional US equities.
Corporate governance developments accompany the financial reporting cycle. Puma Biotechnology convened its 2026 Annual Meeting of Stockholders. During this assembly, shareholders elected eight directors to serve one-year terms, with the next annual meeting scheduled for 2027. The elected directors include Alan H. Auerbach, Alessandra Cesano, and Troy E. Wilson, among others. Voting tallies demonstrated varied support levels for the nominees, with certain candidates receiving in excess of 37 million shares in favor.
Financial performance for the first quarter of 2026 presented challenges relative to consensus estimates. Puma Biotechnology reported a net loss per share of -$0.04, which fell short of the forecasted $0.00. Revenue for the quarter was recorded at $44.8 million, missing the anticipated figure of $49 million. This discrepancy resulted in a revenue surprise of -8.57%. These financial metrics have drawn attention from market participants.
Market data for PBYI shows the stock closing at 8.13, representing a change of +0.170 or +2.14% at 15:59:59 USD. After-hours trading data recorded at 16:10:04 indicates a price of 8.130 with a change of 0.000 or 0.00%. The equity has experienced volatility, with price points ranging from 7.88 to 8.2 across a one-year timeline.
Investment tools and risk management platforms are available to assist with PBYI trades. Vision AI technology analyzes chart patterns to provide risk management plans, including entry points, stop-loss levels, and profit targets, within a sixty-second timeframe. A promotional offer for a July sale of InvestingPro at 60% off is noted.